Cetuximab Concomitant with Second-Line Radiation Therapy in Patients with Locally Advanced Recurrent Squamous Cell Head and Neck Cancer

We presented 9 recurrent head and neck carcinoma patients. Priorly all of them had received radiochemotherapy. We used cetuximab and irradiation concomitantly. Overall survival analysis of the patients was performed using the Kaplan-Meier method on SPSS version 15.0. Based on this calculation, mean...

Descripción completa

Detalles Bibliográficos
Autores principales: Akmansu, Muge, Buyukberber, Suleyman, Iren, Sevilay, Demirci, Umut, Kanyilmaz, Gul, Coskun, Ugur, Bora, Huseyin
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Published: December 2010
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3100271/
https://www.ncbi.nlm.nih.gov/pubmed/21611102
http://dx.doi.org/10.1159/000323204
Descripción
Sumario:We presented 9 recurrent head and neck carcinoma patients. Priorly all of them had received radiochemotherapy. We used cetuximab and irradiation concomitantly. Overall survival analysis of the patients was performed using the Kaplan-Meier method on SPSS version 15.0. Based on this calculation, mean follow-up duration is 12.8 months. Mean survival time is 19.8 months and annual mean survival rate is 59.3%.

Ejemplares similares